| Donna Yeomans Gardner, LCSW | |
|
3985 Valley Commons Dr, Bozeman, MT 59718-6633 | |
| (406) 813-0239 | |
| Not Available |
| Full Name | Donna Yeomans Gardner |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 34 Years |
| Location | 3985 Valley Commons Dr, Bozeman, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053989244 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | BBH-LCSW-LIC-17983 (Montana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Dandelion Counseling, Llc | 9436570322 | 2 |
News Archive
A novel treatment reduces heart damage after serious heart attacks in two animal models. Injections of two chemicals in a slow-release form significantly reduced the size of the dead heart tissue, known as the infarct, and improved the function of the left ventricle, as compared to untreated subjects.
Akcea Therapeutics, a wholly-owned subsidiary of Isis Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration has granted Orphan Drug Designation to volanesorsen (ISIS-APOCIIIRx) for the treatment of patients with Familial Chylomicronemia Syndrome (FCS).
As the first baby boomers turn 65, Loyola University Hospital has begun offering stem cell transplants to leukemia and lymphoma patients who previously were too old to qualify.
MannKind Corporation today announced that it has submitted, and the U.S. Food and Drug Administration has accepted, MannKind's resubmission of its New Drug Application for AFREZZA™ (insulin human [rDNA origin]) and classified it as a Class 2 resubmission. With the Class 2 designation, the FDA set a corresponding Prescription Drug User Fee Act action date of December 29, 2010.
› Verified 8 days ago
| Entity Name | Dandelion Counseling, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336709476 PECOS PAC ID: 9436570322 Enrollment ID: O20200601002856 |
News Archive
A novel treatment reduces heart damage after serious heart attacks in two animal models. Injections of two chemicals in a slow-release form significantly reduced the size of the dead heart tissue, known as the infarct, and improved the function of the left ventricle, as compared to untreated subjects.
Akcea Therapeutics, a wholly-owned subsidiary of Isis Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration has granted Orphan Drug Designation to volanesorsen (ISIS-APOCIIIRx) for the treatment of patients with Familial Chylomicronemia Syndrome (FCS).
As the first baby boomers turn 65, Loyola University Hospital has begun offering stem cell transplants to leukemia and lymphoma patients who previously were too old to qualify.
MannKind Corporation today announced that it has submitted, and the U.S. Food and Drug Administration has accepted, MannKind's resubmission of its New Drug Application for AFREZZA™ (insulin human [rDNA origin]) and classified it as a Class 2 resubmission. With the Class 2 designation, the FDA set a corresponding Prescription Drug User Fee Act action date of December 29, 2010.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Donna Yeomans Gardner, LCSW 401 Peace Pipe Dr, Bozeman, MT 59715-1768 Ph: (406) 570-4939 | Donna Yeomans Gardner, LCSW 3985 Valley Commons Dr, Bozeman, MT 59718-6633 Ph: (406) 813-0239 |
News Archive
A novel treatment reduces heart damage after serious heart attacks in two animal models. Injections of two chemicals in a slow-release form significantly reduced the size of the dead heart tissue, known as the infarct, and improved the function of the left ventricle, as compared to untreated subjects.
Akcea Therapeutics, a wholly-owned subsidiary of Isis Pharmaceuticals, Inc., announced today that the U.S. Food and Drug Administration has granted Orphan Drug Designation to volanesorsen (ISIS-APOCIIIRx) for the treatment of patients with Familial Chylomicronemia Syndrome (FCS).
As the first baby boomers turn 65, Loyola University Hospital has begun offering stem cell transplants to leukemia and lymphoma patients who previously were too old to qualify.
MannKind Corporation today announced that it has submitted, and the U.S. Food and Drug Administration has accepted, MannKind's resubmission of its New Drug Application for AFREZZA™ (insulin human [rDNA origin]) and classified it as a Class 2 resubmission. With the Class 2 designation, the FDA set a corresponding Prescription Drug User Fee Act action date of December 29, 2010.
› Verified 8 days ago
Heather Jodene Linn, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 6108 W Shadow Dr, Bozeman, MT 59715 Phone: 206-673-6973 | |
Dena Fromberg, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 714 Stoneridge Dr Ste 1, Bozeman, MT 59718 Phone: 406-209-8711 | |
Sarah Marsh, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1610 Ellis St Ste 1a, Bozeman, MT 59715 Phone: 206-482-9120 | |
Barbara Ann Lair-murry, LCSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1087 Stoneridge Dr, Suite 2c, Bozeman, MT 59718 Phone: 406-586-9251 | |
Christine S. Visscher, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 333 Haggerty Ln Ste 14, Bozeman, MT 59715 Phone: 406-586-3767 Fax: 406-586-2326 | |
Vivienne K Riseley, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 115 W Kagy Blvd Ste O, Bozeman, MT 59715 Phone: 406-282-3055 | |
Vicki Joy Deboer, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 420 W Mendenhall St, Bozeman, MT 59715 Phone: 406-587-1181 Fax: 406-587-1801 |